GLOBAL TROPONIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Troponin Market, By Product Type (Troponin I, Troponin T, Troponin Complex, and Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, and Others), By End User (Hospitals, Diagnostics Laboratories, Home Care Settings, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Recent Developments

Key Developments

In October 2023, Mediport, a company that provides a service that monitors interstate transport companies, and GE HealthCare, an independent healthcare technology and diagnostics company, inaugurated the first of its kind One-Stop Clinic to serve cardiology patients. Patients visiting the clinic will receive a same-day diagnosis and care plan.
In 2021, Roche Diagnostics, a company that develops innovative diagnostic products, launched a series of five new intended uses for two key cardiac biomarkers using the Elecsys technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These tests are used for accessing heart attacks in patients. Roche Diagnostics' introduction of five new intended uses for these existing, globally accepted diagnostic solutions means more people could benefit from improved cardiovascular diagnostics.

Global Troponin Market Report Snapshots